Summit Therapeutics Inc (NASDAQ:SMMT) currently has a daily average trading volume of 4.06M but it saw 4409390 shares traded in last market. With a market cap of 18.74B USD, the company’s current market price of $25.41 came rising about 4.18 while comparing to the previous closing price of $24.39. In past 52 weeks, the stock remained buoying in the range of price level as high as $36.91 and as low as $2.10.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Citigroup which upgraded the stock as “Buy” in its note to investors issued on March 26, 2025, recommending a price target of between $23 and $35 for it. Evercore ISI issued its recommendations for the stock as it initiated the price target for the stock is $30.
Over the week, SMMT’s stock price is moving 11.69% up while it is -7.09% when we observe its performance for the past one month. Year-to-date it is 42.39% up and over the past year, the stock is showing an upside performance of 472.30%.
Currently, Summit Therapeutics Inc’s total number of outstanding shares is 741.61M with 84.31% of that held by the insiders while 13.54% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -69.33% and return on equity (ROE) at -123.93%. Stock’s beta reads -0.95. Stock has a price to book (P/B) ratio of 54.73. Its return on asset (ROA) is -85.89% on average.
